首页> 美国卫生研究院文献>other >A Novel Cyclic Adenosine Monophosphate–Responsive Luciferase Reporter Incorporating a Nonpalindromic Cyclic Adenosine Monophosphate Response Element Provides Optimal Performance for Use in G Protein–Coupled Receptor Drug Discovery Efforts
【2h】

A Novel Cyclic Adenosine Monophosphate–Responsive Luciferase Reporter Incorporating a Nonpalindromic Cyclic Adenosine Monophosphate Response Element Provides Optimal Performance for Use in G Protein–Coupled Receptor Drug Discovery Efforts

机译:结合非回文的环状单磷酸腺苷响应元件的新型环状腺苷单磷酸反应性荧光素酶报道基因提供了最佳的性能可用于G蛋白偶联受体药物的发现。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The authors report the characterization of a novel cyclic adenosine monophosphate (cAMP)–responsive luciferase (Luc) reporter that exhibits optimal performance in high-throughput screens of agonist binding at G protein–coupled receptors (GPCRs). This reporter (RIP1-CRE-Luc) incorporates a nonpalindromic cAMP response element (CRE) originally identified within the 5′ promoter of the rat insulin 1 gene (RIP1). When multimerized and fused to the coding sequence of firefly luciferase, the CRE of RIP1 allows for the efficient activation of luciferase expression by cAMP-elevating agents or by cAMP itself. Of primary importance is the demonstration that RIP1-CRE-Luc does not exhibit the relatively high levels of basal luciferase activity inherent to reporters incorporating the palindromic CRE first identified in the somatostatin gene promoter. Furthermore, studies of HEK cells expressing class II GPCRs for the cAMP-elevating hormones GLP-1, GIP, and glucagon demonstrate that RIP1-CRE-Luc affords a much wider dynamic range of activation upon exposure to agonist. Such properties of RIP1-CRE-Luc indicate its usefulness as a new and powerful tool for the identification of small-molecule compounds with receptor-stimulating actions or for the identification of constitutively active orphan receptors with cAMP-signaling properties.
机译:作者报告了一种新型的环状单磷酸腺苷(cAMP)响应荧光素酶(Luc)报道分子的表征,该报道分子在高通量筛选G蛋白偶联受体(GPCR)的激动剂时表现出最佳性能。该报道分子(RIP1-CRE-Luc)结合了最初在大鼠胰岛素1基因(RIP1)5'启动子中鉴定的非回文cAMP反应元件(CRE)。当与萤火虫荧光素酶的编码序列多聚并融合时,RIP1的CRE可以通过cAMP升高剂或cAMP本身有效激活荧光素酶表达。最重要的证明是,RIP1-CRE-Luc没有表现出相对较高水平的基础萤光素酶活性,这是报道最早整合了生长抑素基因启动子的回文CRE的报道分子所固有的。此外,对表达cAMP升高激素GLP-1,GIP和胰高血糖素的II类GPCR的HEK细胞的研究表明,RIP1-CRE-Luc在暴露于激动剂后可提供更大的激活动态范围。 RIP1-CRE-Luc的这种特性表明,它可用作鉴定具有受体刺激作用的小分子化合物或鉴定具有cAMP信号传递特性的组成型活性孤儿受体的新型强大工具。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号